Main menu

Cancer Genomics Consortium (CGC) Annual Meeting 2026

Houston, TX

Overview

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. Sequence short to ultra-long DNA/RNA fragments, for a streamlined and rapid solution to comprehensively characterise cancer and tumour research samples: from SNVs to epigenetic alterations and large-scale structural aberrations.

We're looking forward to CGC 2026. Visit the Oxford Nanopore booth to speak to our experts about your application.

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Spanish flag